Yun YC, Jende JME, Garhofer F, Wolf S, et al. Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma. J Neurooncol 2025 Apr 17. doi: 10.1007/s11060-025-05037.
PMID: 40244521